Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Medical research

How the body responds to exercise at the cellular level

Researchers have long been fascinated by the possibility that exercise causes various cells in our body to produce molecules that benefit human health, says Jonathan Long, assistant professor of pathology at Stanford University.

Cardiology

Researchers create breakthrough in vascularized heart organoids

An Australian research team led by QIMR Berghofer has succeeded in introducing a vascular system into tiny living and beating model human heart muscles, an achievement which it's hoped will accelerate progress toward the ...

Cardiology

Progress with organoids: A mini-heart in a Petri dish

A team at the Technical University of Munich (TUM) has induced stem cells to emulate the development of the human heart. The result is a sort of "mini-heart" known as an organoid. It will permit the study of the earliest ...

page 5 from 40